These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 14688007)

  • 21. [A case of primary malignant lymphoma of the pararectal space].
    Tanaka M; Matsuzaki J; Kitami K; Hirokawa M
    Hinyokika Kiyo; 2002 Sep; 48(9):561-4. PubMed ID: 12402484
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term survival after autologous peripheral blood stem cell transplantation in two patients with malignant rhabdoid tumor of the kidney.
    Koga Y; Matsuzaki A; Suminoe A; Hatano M; Saito Y; Kinoshita Y; Tajiri T; Taguchi T; Kohashi K; Oda Y; Tsuneyoshi M; Hara T
    Pediatr Blood Cancer; 2009 Jul; 52(7):888-90. PubMed ID: 19260106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
    van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
    J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral primary non-Hodgkin's lymphoma of the adrenal glands with adrenal insufficiency: a case report.
    Utsunomiya M; Takatera H; Itoh H; Tsujimura T; Itatani H
    Hinyokika Kiyo; 1992 Mar; 38(3):311-4. PubMed ID: 1523986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic effect of interferon-alpha for exacerbation of hepatitis B after high-dose chemotherapy.
    Matano S; Kobayashi K; Ohta H; Minouchi K; Sanada T; Sugimoto T
    Acta Haematol; 2001; 106(3):138-40. PubMed ID: 11713383
    [No Abstract]   [Full Text] [Related]  

  • 26. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Fangusaro JR; Jubran RF; Allen J; Gardner S; Dunkel IJ; Rosenblum M; Atlas MP; Gonzalez-Gomez I; Miller D; Finlay JL
    Pediatr Blood Cancer; 2008 Mar; 50(3):715-7. PubMed ID: 17009232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression of the tumor after withdrawal of cyclosporine in relapsed extranodal natural killer/T cell lymphoma following allogeneic hematopoietic stem cell transplantation.
    Kako S; Izutsu K; Oshima K; Sato H; Kanda Y; Motokura T; Chiba S; Kurokawa M
    Am J Hematol; 2007 Oct; 82(10):937-9. PubMed ID: 17663389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recent therapeutic progress in non-Hodgkin lymphoma: focusing on diffuse large B-cell lymphoma and follicular lymphoma].
    Ogura M
    Rinsho Ketsueki; 2008 Oct; 49(10):1434-50. PubMed ID: 18833928
    [No Abstract]   [Full Text] [Related]  

  • 29. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J; Finlay J; Sposto R; Ji L; Saly M; Zacharoulis S; Asgharzadeh S; Abromowitch M; Olshefski R; Halpern S; Dubowy R; Comito M; Diez B; Kellie S; Hukin J; Rosenblum M; Dunkel I; Miller DC; Allen J; Gardner S
    Pediatr Blood Cancer; 2008 Feb; 50(2):312-8. PubMed ID: 17668858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire.
    Soussain C; Hoang-Xuan K; Taillandier L; Fourme E; Choquet S; Witz F; Casasnovas O; Dupriez B; Souleau B; Taksin AL; Gisselbrecht C; Jaccard A; Omuro A; Sanson M; Janvier M; Kolb B; Zini JM; Leblond V;
    J Clin Oncol; 2008 May; 26(15):2512-8. PubMed ID: 18413641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
    McQuaker IG; Haynes AP; Iqbal A; Russell NH
    Bone Marrow Transplant; 1996 Jul; 18(1):263-4. PubMed ID: 8832036
    [No Abstract]   [Full Text] [Related]  

  • 32. Effective treatment for de novo hepatitis B with nucleotide analogue in patients with hematological malignancies.
    Ueda Y; Marusawa H; Ichinohe T; Kadowaki N; Uchiyama T; Chiba T
    Am J Hematol; 2009 May; 84(5):315-6. PubMed ID: 19350661
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group.
    Arranz R; Conde E; Grande C; Mateos MV; Gandarillas M; Albo C; Lahuerta JJ; Fernández-Rañada JM; Hernández MT; Alonso N; García Vela JA; Garzón S; Rodríguez J; Caballero D;
    Eur J Haematol; 2008 Mar; 80(3):227-35. PubMed ID: 18088400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Testicular lymphoma, intraocular (vitreoretinal) lymphoma, and brain lymphoma: involvement of three immunoprivileged sites in one patient.
    Pe'er J; Rowe JM; Frenkel S; Dann EJ
    Am J Hematol; 2010 Aug; 85(8):631-3. PubMed ID: 20658596
    [No Abstract]   [Full Text] [Related]  

  • 35. Secondary myelodysplastic syndrome following bone marrow transplantation: report of two cases.
    Chan T; Juneja S; Wolf M; Januszewicz E; Cooper I
    Bone Marrow Transplant; 1994 Feb; 13(2):145-8. PubMed ID: 7515740
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
    Coso D; Sebban C; Boulat O; Biron P; Rey J; Aurran T; Chabannon C; Xerri L; Chetaille B; Esterni B; Ivanov V; Stoppa AM; Schiano de Collela JM; Gastaut JA; Maraninchi D; Bouabdallah R
    Bone Marrow Transplant; 2006 Aug; 38(3):217-22. PubMed ID: 16770316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fourth biannual report of the Cochrane Haematological Malignancies Group.
    Kober T; Hülsewede H; Bohlius J; Engert A
    J Natl Cancer Inst; 2006 Apr; 98(8):E1. PubMed ID: 16622111
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of localized nasal NK/T-cell lymphoma].
    Yamaguchi M
    Rinsho Ketsueki; 2008 Aug; 49(8):553-8. PubMed ID: 18800601
    [No Abstract]   [Full Text] [Related]  

  • 39. Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
    Eckrich MJ; Domm J; Ho R; Whitlock JA; Frangoul H
    Pediatr Blood Cancer; 2009 Dec; 53(7):1327-8. PubMed ID: 19760777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant lymphoma of the uterine cervix: a case report and review of literature.
    Biswal BM; Sharma A; Sharma MC; Prasad RR; Roy K; Rath GK
    J Indian Med Assoc; 1997 Jul; 95(7):434, 440. PubMed ID: 9425847
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.